–
[로이터=연합뉴스 자료사진]
–
(Brussels = Yonhap News) Correspondent Kim Jong-un = The European Medicines Agency (EMA) recommends conditional marketing approval for a novel coronavirus infection (Corona 19) vaccine jointly developed by multinational pharmaceutical company AstraZeneca and Oxford University in the UK on the 29th (local time). Revealed.
The EMA has recommended the vaccine for people 18 years of age or older.
AstraZeneca-Oxford University vaccine is the third COVID-19 vaccine that EMA recommended conditional use in the EU, following a vaccine developed by US pharmaceutical companies Pfizer-Germany Bioentech and US Modena.
The final decision is now made by the European Commission, the executive branch of the European Union, and once official approval is granted, vaccinations can be initiated within EU member states.
<저작권자(c) 연합뉴스,
Unauthorized reproduction-prohibition of redistribution>
2021/01/30 00:20 sent
–
